<?xml version="1.0" encoding="UTF-8"?>

<rss xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" version="2.0">
 xmlns:blogChannel="http://backend.userland.com/blogChannelModule"
>

<channel>
<itunes:category text="Health"/>
<itunes:explicit>no</itunes:explicit>
<itunes:subtitle>All Worldwide Medical &amp; Health Events powered by HON.</itunes:subtitle>
<itunes:summary>Stay uptodate on the evolution of the health/medical conferences and events on Pharmacology.
Consult national &amp; international medical health events'reposotory offered by HON.</itunes:summary>
<itunes:owner><itunes:name>HON</itunes:name><itunes:email>webmaster@healthonnet.org</itunes:email></itunes:owner>
<itunes:author>webmaster@healthonnet.org</itunes:author>
<title>HON - Conferences &#x26; Events on Pharmacology</title>
<link>http://www.hon.ch/Conf/Theme/G01.703.html</link>
<description>Stay uptodate on the evolution of the health/medical conferences and events on Pharmacology. Consult national &#x26;amp; international medical health events&#x27;reposotory offered by HON.</description>
<language>en-fr-it</language>
<copyright>Copyright 2006, HON</copyright>
<webMaster>webmaster@healthonnet.org</webMaster>

<item>
<itunes:author/>
<itunes:subtitle/>
<itunes:summary></itunes:summary>
<itunes:duration/>
<itunes:keywords/>
<title>15. Innere Medizin Update Refresher (Jun 12-16, 2012, Zurich, Switzerland, Europe)</title>
<link>http://www.hon.ch/cgi-bin/confevent?aff2+CONF12503</link>
<description><![CDATA[<img src=&quot;http://www.fomf.ch/uploads/media_files/picture/orig/080/080_903_12652c7e8deaf607ac46344e20b65a09f7b2c1f2.jpg&quot;  width="" border=&quot;0&quot;  align=&quot;left&quot;>]]><![CDATA[<A HREF="http://asp.readspeaker.net/cgi-bin/honrsone?customerid=1003380&lang=en&id=1&type=2&url=http://www.hon.ch/RSS/AUDIO/Conf/THEME/G01.703.mp3" class=menu target="rs"><IMG SRC="http://www.hon.ch/TTS/img/audio_en.jpg" BORDER=0 ALIGN=MIDDLE ALT="Cliquez pour &eacute;couter ce texte" WIDTH=52 HEIGHT=16></A> ]]>Der Innere Medizin Update-Refresher zahlt mit insgesamt vier Terminen im Jahr und ca. 2000 teilnehmenden Arzten zu einer der grossten und beliebtesten Innere Medizin Fortbildungen im deutschsprachigen Raum. In kurzen Blocken werden die neuesten diagnostischen und therapeutischen Leitlinien der Inneren Medizin behandelt. Alle Teilnehmer erhalten ein umfassendes Kursbuch mit den Power-Point-Prasentationen der Vortrage.  &#x3C;br&#x3E; Dieses praxisorientierte Internisten Update bietet inuber  30 Stunden ein:  umfassendes Update fur die Klinik undPraxis - Update  fur Internisten und Allgemeinmediziner umfassendes Themenreview fur Assistenzarzte als Vorbereitung auf die Facharztprufung</description>
<pubDate>12 Jun 2012 08:00:00 +0000</pubDate>
<enclosure length="9000000" url="http://www.hon.ch/cgi-bin/RSS/ecouter_conf.mp3?1_en_G01.703" type="audio/mpeg" />
</item>
<item>
<itunes:author/>
<itunes:subtitle/>
<itunes:summary></itunes:summary>
<itunes:duration/>
<itunes:keywords/>
<title>International Conference and Exhibition on Biowaivers &#x26; Biosimilars (Sep. 10-12, 2012, San Antonio, Texas, USA, North America)</title>
<link>http://www.hon.ch/cgi-bin/confevent?aff2+CONF12950</link>
<description><![CDATA[<A HREF="http://asp.readspeaker.net/cgi-bin/honrsone?customerid=1003380&lang=en&id=2&type=2&url=http://www.hon.ch/RSS/AUDIO/Conf/THEME/G01.703.mp3" class=menu target="rs"><IMG SRC="http://www.hon.ch/TTS/img/audio_en.jpg" BORDER=0 ALIGN=MIDDLE ALT="Cliquez pour &eacute;couter ce texte" WIDTH=52 HEIGHT=16></A> ]]>The International Conference and Exhibition on Biowaivers &#x26; Biosimilars (Biosimilars-2012), is offering a formal forum for the exchange of ideas concerning the development and progress of research in the areas of drug discovery, clinical trials, regulatory and economic considerations towards Biosimilars and Waiver for Bioequivalence Studies, BCS Biowaiver Studies, Dosage forms, Dissolution Testing and IVIVC. This conference is proudly presented by OMCIS Group and will be held at Hilton San Antonio Airport, USA during September 10-12, 2012.  Biosimilars-2012, a three day event  will bringing together scientists from academia, the pharmaceutical industry, the biotechnology industry and regulatory agencies for the opportunity to learn of and discuss new initiatives for finding a better way to develop new drugs with biosimilarity and improve the quality of existing drug products. &#x3C;br&#x3E;Important Dates: Avail the early bird discounts and register on/before May 29, 2012. Abstract Submission closes on: June 04, 2012  Submit your abstract to biosimilars2012@omicsonline.org</description>
<pubDate>10 Sep 2012 08:00:00 +0000</pubDate>
<enclosure length="9000000" url="http://www.hon.ch/cgi-bin/RSS/ecouter_conf.mp3?2_en_G01.703" type="audio/mpeg" />
</item>
<item>
<itunes:author/>
<itunes:subtitle/>
<itunes:summary></itunes:summary>
<itunes:duration/>
<itunes:keywords/>
<title>Internal Medicine Review for Nurse Practitioners, Physician Assistants &#x26; Primary Care Physicians (Sep. 12-14, 2012, Rochester, Minnesota, USA, North America)</title>
<link>http://www.hon.ch/cgi-bin/confevent?aff2+CONF12902</link>
<description><![CDATA[<A HREF="http://asp.readspeaker.net/cgi-bin/honrsone?customerid=1003380&lang=en&id=3&type=2&url=http://www.hon.ch/RSS/AUDIO/Conf/THEME/G01.703.mp3" class=menu target="rs"><IMG SRC="http://www.hon.ch/TTS/img/audio_en.jpg" BORDER=0 ALIGN=MIDDLE ALT="Cliquez pour &eacute;couter ce texte" WIDTH=52 HEIGHT=16></A> ]]>This 14th annual conference has an emphasis on clinical care issues confronting busy health care providers and new this year, will include lectures incorporating current pharmacology content.   An interactive case study formatfocuses on expanding  evidence-based care managementstrategies for clinical  decision making. Expert speakerspresent clinical topics  chosen for applicability to primarycare practice settings  with diverse topics to includecardiovascular, internal  medicine, women&#x27;s health,endocrinology, pulmonology,  preventative medicine and more.  The program is designed for nurse practitioners, physician assistants and primary care providers. Breakout sessions enable the learner to customize their educational experience.    Category 1 Credits: 21 Credits   CourseRegistration: $495 Student Course Registration: $395Satellite (LaCrosse, WI) Registration: $395   See ourwebsite at: http://www.mayo.edu/cme/internal-medicine-and-subspecialties-2012r432  For more informationcontact: Mayo School of Continuous Professional Development200 First Street SW Rochester, MN 55905 Phone:1-800-323-2688 (U.S.) or 1-507-284-2509 (outside of  U.S.)Fax: 1-507-284-0532 Website: www.mayo.edu/cme E-mail:cvcme@mayo.edu</description>
<pubDate>12 Sep 2012 08:00:00 +0000</pubDate>
<enclosure length="9000000" url="http://www.hon.ch/cgi-bin/RSS/ecouter_conf.mp3?3_en_G01.703" type="audio/mpeg" />
</item>
<item>
<itunes:author/>
<itunes:subtitle/>
<itunes:summary></itunes:summary>
<itunes:duration/>
<itunes:keywords/>
<title>Pharmacology for Advanced Practice Clinicians - San Francisco (Sep. 10-16, 2012, San Francisco, California, USA, North America)</title>
<link>http://www.hon.ch/cgi-bin/confevent?aff2+CONF12844</link>
<description><![CDATA[<A HREF="http://asp.readspeaker.net/cgi-bin/honrsone?customerid=1003380&lang=en&id=4&type=2&url=http://www.hon.ch/RSS/AUDIO/Conf/THEME/G01.703.mp3" class=menu target="rs"><IMG SRC="http://www.hon.ch/TTS/img/audio_en.jpg" BORDER=0 ALIGN=MIDDLE ALT="Cliquez pour &eacute;couter ce texte" WIDTH=52 HEIGHT=16></A> ]]>Advanced practice clinicians now have the ability to apply for prescriptive authority in all states. With the advent of health reform and the spotlight on primary care, APCswill play a  significant role in handling the increasednumber of  patients accessing the health care system. It isessential  to be up-to-date on the latest pharmaceuticalsavailable  for a variety of acute and chronic conditions,including  therapeutic effects, monitoring patient response,and  managing side effects. Achieving prescriptive authority also significantly improves marketability in this changing economic and health care environment. &#x3C;br&#x3E;&#x3C;br&#x3E;Forregistration, pls call Contemporary Forums at 800-377- 7707,fax us 800-329-9923 or by email info@cforums.com</description>
<pubDate>10 Sep 2012 08:00:00 +0000</pubDate>
<enclosure length="9000000" url="http://www.hon.ch/cgi-bin/RSS/ecouter_conf.mp3?4_en_G01.703" type="audio/mpeg" />
</item>
<item>
<itunes:author/>
<itunes:subtitle/>
<itunes:summary></itunes:summary>
<itunes:duration/>
<itunes:keywords/>
<title>4th European Workshop on Lipid Mediators (Sep. 27-28, 2012, Paris, France, Europe)</title>
<link>http://www.hon.ch/cgi-bin/confevent?aff2+CONF12600</link>
<description><![CDATA[<img src=&quot;http://workshop-lipid.eu/pictures/BannerPA3tailleSiteW.jpg&quot;  width="" border=&quot;0&quot;  align=&quot;left&quot;>]]><![CDATA[<A HREF="http://asp.readspeaker.net/cgi-bin/honrsone?customerid=1003380&lang=en&id=5&type=2&url=http://www.hon.ch/RSS/AUDIO/Conf/THEME/G01.703.mp3" class=menu target="rs"><IMG SRC="http://www.hon.ch/TTS/img/audio_en.jpg" BORDER=0 ALIGN=MIDDLE ALT="Cliquez pour &eacute;couter ce texte" WIDTH=52 HEIGHT=16></A> ]]>This biennial two-day workshop is primarily addressed to scientists interested in the field of bioactive lipid mediators. Scientists from across and outside Europe have been invited to share their expertise in a number of research topics that include the state-of-the-art  knowledgeof the biochemistry, molecular biology and  physiology oflipids as signalling molecules, their  involvement ininflammation, and their specific roles in  several diseaseconditions.  &#x3C;br&#x3E;&#x3C;b&#x3E;The workshop has two main goals:  &#x3C;/b&#x3E; &#x3C;li&#x3E;1) to bring together researchers to discuss the latest results and developments in this area.&#x3C;/li&#x3E;&#x3C;li&#x3E;2) to promote interaction and exchange of ideas among the different laboratories. &#x3C;/li&#x3E;For this Fourth Workshop, a special emphasis will be placed on exploring: The 5 main sessions will concern:    &#x3C;li&#x3E; omega-3 polyunsaturated fatty acids&#x3C;/li&#x3E;    &#x3C;li&#x3E;  lipid mediators in the resolution ofinflammation&#x3C;/li&#x3E;    &#x3C;li&#x3E;lipidomic analysis&#x3C;/li&#x3E;    &#x3C;li&#x3E;prostanoid receptor pharmacology&#x3C;/li&#x3E;    &#x3C;li&#x3E; innate immunity&#x3C;/li&#x3E;The registration fees are 200 euros (full price) and 50euros for the students / post-docs .</description>
<pubDate>27 Sep 2012 08:00:00 +0000</pubDate>
<enclosure length="9000000" url="http://www.hon.ch/cgi-bin/RSS/ecouter_conf.mp3?5_en_G01.703" type="audio/mpeg" />
</item>
<item>
<itunes:author/>
<itunes:subtitle/>
<itunes:summary></itunes:summary>
<itunes:duration/>
<itunes:keywords/>
<title>Pharmacology for Advanced Practice Clinicians - Washington, DC (Oct. 08-14, 2012, California, USA, North America)</title>
<link>http://www.hon.ch/cgi-bin/confevent?aff2+CONF12845</link>
<description><![CDATA[<A HREF="http://asp.readspeaker.net/cgi-bin/honrsone?customerid=1003380&lang=en&id=6&type=2&url=http://www.hon.ch/RSS/AUDIO/Conf/THEME/G01.703.mp3" class=menu target="rs"><IMG SRC="http://www.hon.ch/TTS/img/audio_en.jpg" BORDER=0 ALIGN=MIDDLE ALT="Cliquez pour &eacute;couter ce texte" WIDTH=52 HEIGHT=16></A> ]]>Advanced practice clinicians now have the ability to apply for prescriptive authority in all states*. With the advent of health reform and the spotlight on primary care, APCswill play a  significant role in handling the increasednumber of  patients accessing the health care system. It isessential  to be up-to-date on the latest pharmaceuticalsavailable  for a variety of acute and chronic conditions,including  therapeutic effects, monitoring patient response,and  managing side effects. Achieving prescriptive authority also significantly improves marketability in this changing economic and health care environment. &#x3C;br&#x3E;&#x3C;br&#x3E;Forregistration, pls call Contemporary Forums at 800-377- 7707,by fax 800-329-9923 or email us at info@cforums.com</description>
<pubDate>08 Oct 2012 08:00:00 +0000</pubDate>
<enclosure length="9000000" url="http://www.hon.ch/cgi-bin/RSS/ecouter_conf.mp3?6_en_G01.703" type="audio/mpeg" />
</item>
<item>
<itunes:author/>
<itunes:subtitle/>
<itunes:summary></itunes:summary>
<itunes:duration/>
<itunes:keywords/>
<title>Pharmacology for Advanced Practice Clinicians - Las Vegas (Nov. 05-11, 2012, Las Vegas, Nevada, USA, North America)</title>
<link>http://www.hon.ch/cgi-bin/confevent?aff2+CONF12846</link>
<description><![CDATA[<A HREF="http://asp.readspeaker.net/cgi-bin/honrsone?customerid=1003380&lang=en&id=7&type=2&url=http://www.hon.ch/RSS/AUDIO/Conf/THEME/G01.703.mp3" class=menu target="rs"><IMG SRC="http://www.hon.ch/TTS/img/audio_en.jpg" BORDER=0 ALIGN=MIDDLE ALT="Cliquez pour &eacute;couter ce texte" WIDTH=52 HEIGHT=16></A> ]]>Advanced practice clinicians now have the ability to apply for prescriptive authority in all states*. With the advent of health reform and the spotlight on primary care, APCs will play a significant role in handling the increased number of patients accessing the health care system. It is essential to be up-to-date on the latest pharmaceuticals available for a variety of acute and chronic conditions, including therapeutic effects, monitoring patient  response, and managing side effects. Achieving  prescriptiveauthority also significantly improves  marketability in thischanging economic and health care  environment. &#x3C;br&#x3E;&#x3C;br&#x3E;ForRegistration,please call Contemporary Forums at 800-377-7707, by fax 800-329-9923 or by email at  info@cforums.com</description>
<pubDate>05 Nov 2012 08:00:00 +0000</pubDate>
<enclosure length="9000000" url="http://www.hon.ch/cgi-bin/RSS/ecouter_conf.mp3?7_en_G01.703" type="audio/mpeg" />
</item>
<item>
<itunes:author/>
<itunes:subtitle/>
<itunes:summary></itunes:summary>
<itunes:duration/>
<itunes:keywords/>
<title>16. Innere Medizin Update Refresher   40 Credits SGIM/SGAM angefragt (Nov. 27-Dec 01, 2012, Zurich, Switzerland, Europe)</title>
<link>http://www.hon.ch/cgi-bin/confevent?aff2+CONF12471</link>
<description><![CDATA[<img src=&quot;http://www.fomf.ch/uploads/media_files/picture/orig/080/080_903_12652c7e8deaf607ac46344e20b65a09f7b2c1f2.jpg&quot;  width="" border=&quot;0&quot;  align=&quot;left&quot;>]]><![CDATA[<A HREF="http://asp.readspeaker.net/cgi-bin/honrsone?customerid=1003380&lang=en&id=8&type=2&url=http://www.hon.ch/RSS/AUDIO/Conf/THEME/G01.703.mp3" class=menu target="rs"><IMG SRC="http://www.hon.ch/TTS/img/audio_en.jpg" BORDER=0 ALIGN=MIDDLE ALT="Cliquez pour &eacute;couter ce texte" WIDTH=52 HEIGHT=16></A> ]]>Der Innere Medizin Update-Refresher zahlt mit insgesamt vier Terminen im Jahr und ca. 2000 teilnehmenden Arzten zu einer der grossten und beliebtesten Innere Medizin Fortbildungen im deutschsprachigen Raum. In kurzen Blocken werden die neuesten diagnostischen und therapeutischen Leitlinien der Inneren Medizin behandelt. Alle Teilnehmer erhalten ein umfassendes Kursbuch mit den Power-Point-Prasentationen der Vortrage.   Dieses praxisorientierteInternisten Update bietet in uber  30 Stunden ein: umfassendes Update fur die Klinik und Praxis - Update  furInternisten und Allgemeinmediziner  umfassendes Themenreviewfur Assistenzarzte als  Vorbereitung auf die Facharztprufung</description>
<pubDate>27 Nov 2012 08:00:00 +0000</pubDate>
<enclosure length="9000000" url="http://www.hon.ch/cgi-bin/RSS/ecouter_conf.mp3?8_en_G01.703" type="audio/mpeg" />
</item>
<item>
<itunes:author/>
<itunes:subtitle/>
<itunes:summary></itunes:summary>
<itunes:duration/>
<itunes:keywords/>
<title>The 6th International Conference on Ocular Infections (ICOI) (Mar. 07-10, 2013, Santa Monica, California, USA, North America)</title>
<link>http://www.hon.ch/cgi-bin/confevent?aff2+CONF12693</link>
<description><![CDATA[<A HREF="http://asp.readspeaker.net/cgi-bin/honrsone?customerid=1003380&lang=en&id=9&type=2&url=http://www.hon.ch/RSS/AUDIO/Conf/THEME/G01.703.mp3" class=menu target="rs"><IMG SRC="http://www.hon.ch/TTS/img/audio_en.jpg" BORDER=0 ALIGN=MIDDLE ALT="Cliquez pour &eacute;couter ce texte" WIDTH=52 HEIGHT=16></A> ]]>Infections of the eye continue to challenge clinicians around  the world to make an accurate, rapid diagnosis, as well as  providing optimal therapy given the emergence of spread of  antimicrobial resistance. Bringing experts from around the world providing the latest  clinical and basic research advances to help meet these  challenges.</description>
<pubDate>07 Mar 2013 08:00:00 +0000</pubDate>
<enclosure length="9000000" url="http://www.hon.ch/cgi-bin/RSS/ecouter_conf.mp3?9_en_G01.703" type="audio/mpeg" />
</item>
<item>
<itunes:author/>
<itunes:subtitle/>
<itunes:summary></itunes:summary>
<itunes:duration/>
<itunes:keywords/>
<title>CINP Thematic Meeting on Pharmacogenomics and Personalised Medicine in Psychiatry (Apr. 21-23, 2013, Jerusalem, Israel, Middle East)</title>
<link>http://www.hon.ch/cgi-bin/confevent?aff2+CONF12876</link>
<description><![CDATA[<A HREF="http://asp.readspeaker.net/cgi-bin/honrsone?customerid=1003380&lang=en&id=10&type=2&url=http://www.hon.ch/RSS/AUDIO/Conf/THEME/G01.703.mp3" class=menu target="rs"><IMG SRC="http://www.hon.ch/TTS/img/audio_en.jpg" BORDER=0 ALIGN=MIDDLE ALT="Cliquez pour &eacute;couter ce texte" WIDTH=52 HEIGHT=16></A> ]]>The program will provide an up to date introduction to pharmacogenomics and personalised medicine in psychiatry for general psychiatrists as well as an opportunity to exchange the latest data for specialists and researchers  inthe area.  Because of the intense interest of the pharmaceutical industry in prediction of response to psychotropic drugs and the critical importance of adverse event prediction, we expect that the Thematic Meeting will be the focus of several critical industry related events. Ethical, economic, social and legal aspects will be considered as well the implementation of personalised medicine in clinical practice.</description>
<pubDate>21 Apr 2013 08:00:00 +0000</pubDate>
<enclosure length="9000000" url="http://www.hon.ch/cgi-bin/RSS/ecouter_conf.mp3?10_en_G01.703" type="audio/mpeg" />
</item>
</channel>
</rss>
